Live feed
Filing
SC 13D
SC 13D0001068238-23-000119·Elicio Therapeutics, Inc.
Schedule 13D ownership disclosure
Elicio Therapeutics, Inc.
Security class unavailable · CUSIP: 28657F103
Event date: 2023-06-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 707,164
- Percent of class
- 8.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001068238-23-000119
- Form type
- SC 13D
- Filer
- Elicio Therapeutics, Inc.
- CIK
- CIK 1601485
- Filed
- Jun 14, 2023
- Reporting period
- Jun 01, 2023
- Description
- Schedule 13D beneficial ownership